These advantages prove the value of being extremely attentive to the selection of the bacteriostatic diluent and reconstitution solution
To illustrate, the authors of that aforementioned 2012 review referred to a multicenter study of 80 children in which subjects received a daily subcutaneous injection equal to 30mcg/kg
You may also experience some other reactions immediately after the injection is administered
Adverse reactions: mild transient diarrhea, polycythemia vera, peripheral vascular thrombosis, transient rash itching, bloating sensation
Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity
Neurological recovery: B12-dependent myelin sheath maintenance is relevant not only in neurological FIP presentations but in any cat whose systemic illness has produced peripheral neurological effects including the generalised weakness and proprioceptive deficits seen in severe wet FIP cases
